Cellulitis and Abscess Management in the Era of Resistance to Antibiotics (CAMERA) Table 5. Initial antibiotic therapy for those with an abscess Antibiotic% (n)Beta-Lactam/Cephalosporin7% (36)Beta-Lactam/Cephalosporin and Mupirocin1% (4)Beta-Lactam/Cephalosporin and Retapamulin<1% (1)Beta-Lactam/Cephalosporin and Sulfonamide5% (23)Beta-Lactam/Cephalosporin, Sulfonamide, and Mupirocin1% (5)Clindamycin8% (39)Clindamycin and Mupirocin2% (10)Clindamycin and Tetracycline<1% (1)Clindamycin, Mupirocin, and Sulfonamide1% (3)Docycycline<1% (2)Docycycline and Fluorqouinalone<1% (1)Doxycycline and Sulfonamide<1% (1)Fluorqouinalone<1% (2)Fluorqouinalone and Mupirocin<1% (1)Fluorqouinalone and Tetracycline1% (3)Mupirocin1% (6)Sulfonamide47% (232)Sulfonamide and Clindamycin1% (5)Sulfonamide and Erythromycin<1% (1)Sulfonamide and Fluorqouinalone<1% (2)Sulfonamide and Metronidazole<1% (1)Sulfonamide and Mupirocin16% (80)Sulfonamide and Retapamulin1% (4)Sulfonamide and Tetracycline<1% (2)Sulfonomide and Mupirocin<1% (1)Sulfonomide and Retapumulin<1% (1)Tetracycline1% (3)Return to Document Current as of March 2011 Internet Citation: Cellulitis and Abscess Management in the Era of Resistance to Antibiotics (CAMERA). March 2011. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/final-reports/mrsa/nc_mrsatab5.html